Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_067c1f6ec07067ca0b49b39431dd1631 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ee50ee0f9d8a84ad46bdce7c509ba43 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_126449c60cad80ebba4225869cd7e672 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e78b8716d976723d4185a04bf434e6c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bfcd6047fec0915b371565343a1cadb5 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-295 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-295 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-31 |
filingDate |
1994-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5a15f06655cbb5da264d3bd02672f0b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a88fffd0896a8bd5be5bc424481fa3e0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96b7e12162c803fc811f65f718db085d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7cc41e14e1f0960120f484715c64e56 |
publicationDate |
1994-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-9426900-A2 |
titleOfInvention |
Hybrid picornaviruses expressing chlamydial epitopes |
abstract |
Hybrid picornaviruses expressing chlamydial epitopes from the major outer membrane protein of Chlamydia trachomatis in a functional form are described. The hybrid viruses grow to high titre in cell culture and when administered to mammals induce an immune response against both the picornavirus and C. trachomatis. The antisera from immunised mammals neutralised both homotypic and heterotypic serovars of C. trachomatis. The hybrid picornaviruses have utility as vaccines and as tools for the generation of immunological reagents. Methods for modifying surface exposed loops of known sequences to produce hybrid proteins are described. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8309102-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9706263-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1885393-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1885393-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7964200-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9951745-A2 |
priorityDate |
1993-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |